Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Botulinum Toxin A in Preventing Keloids
TCTR20150811002Phase 3Not yet recruiting
- Sponsor
- No
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in keloid, sponsored by No. Planned start Sep 2015; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
keloid
Beyond the preview
Go deeper on TCTR20150811002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20150811002.